Grigory Tsaur

13PUBLICATIONS
33CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInfant and child healthHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 09, 2023
A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL.

Alexander Popov, Günter Henze, Julia Roumiantseva

|Sep 23, 2023
Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial.

Larisa Fechina, Alexander Popov, Grigory Tsaur

|Mar 28, 2023
A simple procedure to identify children with B-lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single-point minimal residual disease measurement.

Alexander Popov, Guenter Henze, Julia Roumiantseva

|Jan 30, 2023
Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.

Alexander Popov, Grigory Tsaur, Zhan Permikin

|Apr 12, 2022
Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.

Alexandra Semchenkova, Ekaterina Mikhailova, Alexander Komkov

|Mar 24, 2022
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results.

Alexander Popov, Guenter Henze, Julia Roumiantseva

Pageof 3

Frequent Collaborators

9 joint publications

Alexander Popov

4 joint publications

Elena Zerkalenkova

2 joint publications

Olga Aleinikova

1 joint publications

Alexander E Druy